Are remnant cholesterol levels associated with AKI and MACCEs in patients with prediabetes or diabetes undergoing CABG?
Elevated remnant cholesterol is an independent risk factor for adverse outcomes (AKI and MACCEs) in diabetic and prediabetic patients undergoing CABG, particularly those treated with insulin.
Remnant-C is associated with AKI and MACCEs in patients with diabetes or prediabetes undergoing CABG. The MACCE risk associated with remnant-C is independent of LDL-C and is more pronounced in insulin-treated patients.
Li et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: